Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) Short Interest Update

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO) was the recipient of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 25,100 shares, an increase of 991.3% from the October 31st total of 2,300 shares. Based on an average daily trading volume, of 164,100 shares, the short-interest ratio is currently 0.2 days. Approximately 3.2% of the shares of the company are sold short.

Lipella Pharmaceuticals Price Performance

Shares of NASDAQ LIPO traded down $0.07 during trading on Wednesday, hitting $2.73. 30,794 shares of the company were exchanged, compared to its average volume of 166,022. The firm’s fifty day moving average price is $3.19 and its 200 day moving average price is $3.97. Lipella Pharmaceuticals has a 1 year low of $2.21 and a 1 year high of $12.00.

About Lipella Pharmaceuticals

Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).